SelectSecure Lead 3830
Medtronic Cardiac Rhythm Disease Management · Decision date Jan 8, 2026
What did the FDA decide?
FDA records P030036/S155 as a supplement to PMA P030036, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Jan 8, 2026.
FDA approval order statement
approval for automating the injection molding manufacturing method for Tip to Ring spacer component
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Jan 8, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P030036/S155
- Regulatory pathway
- PMA supplement
- Product code
- NVN
- Decision code
- OK30
- Decision date
- Jan 8, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Drug eluting permanent right ventricular (RV) or right atrial (RA) pacemaker electrodes.
- Product code
- NVN
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P030036. Subsequent supplements may change the device or its indications.
FDA decision timeline
P030036 · Original PMA
MEDTRONIC SELECTSECURE LEAD MODEL 3830
P030036/S154 · Related supplement
MEDTRONIC SELECTSECURE LEAD MODEL 3830
P030036/S155 received
Application receipt date recorded by FDA.
P030036/S155 · FDA decision
30-Day Notice
P030036/S156 · Related supplement
SelectSecure Lead
P030036/S157 · Related supplement
SelectSecure Lead
P030036/S159 · Related supplement
Anchoring Sleeve Kit; SelectSecure Lead
P030036/S158 · Related supplement
SelectSecure Lead Model 3830
P030036/S160 · Related supplement
SelectSecure Lead (3830)
P030036/S161 · Related supplement
SelectSecure Lead 3830
P030036/S162 · Related supplement
MEDTRONIC SELECTSECURE LEAD MODEL 3830
Timeline entries are records held by MedtechLedger for P030036. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P030036
Explore the linked device profile
Other records with product code NVN
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Motorized Outer Tubing Cutter for UltiPace LeadsP960013/S135 | ABBOTT MEDICAL | PMA supplement | Oct 9, 2026 | FDA |
| ABBOTT MEDICAL | PMA supplement | Jun 26, 2026 | FDA | |
IsoFlex LeadsP960030/S085 | ABBOTT MEDICAL | PMA supplement | Jun 26, 2026 | FDA |
| Medtronic Cardiac Rhythm Disease Management | PMA supplement | Jun 24, 2026 | FDA | |
| Medtronic, Inc. | PMA supplement | Jun 24, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Medtronic Cardiac Rhythm Disease Management
- Headquarters
- Not reported
- Brand website
- medtronic.com
- FDA applicant address
- 8200 Coral Sea St. N.E, Mounds View, MN, 55112
Sources and methodology
- Original FDA record: P030036/S155
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records




